Related references
Note: Only part of the references are listed.Rescue of histone hypoacetylation and social deficits by ketogenic diet in a Shank3 mouse model of autism
Luye Qin et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders
Daniel Woike et al.
SCIENTIFIC REPORTS (2022)
Homer1a regulates Shank3 expression and underlies behavioral vulnerability to stress in a model of Phelan-McDermid syndrome
Raozhou Lin et al.
CELL REPORTS (2021)
Restoring glutamate receptosome dynamics at synapses rescues autism-like deficits in Shank3-deficient mice
Enora Moutin et al.
MOLECULAR PSYCHIATRY (2021)
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
Brianna Dyar et al.
GENES (2021)
Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism
Michael S. Breen et al.
MOLECULAR AUTISM (2020)
SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex
Lorenza Culotta et al.
JOURNAL OF NEUROSCIENCE (2020)
Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the literature
Catherine A. Ziats et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2020)
Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment
Catherine A. Ziats et al.
PLOS ONE (2019)
Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome
Andrew R. Mitz et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome)
Nehir Kurtas et al.
JOURNAL OF MEDICAL GENETICS (2018)
Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition
Luye Qin et al.
NATURE NEUROSCIENCE (2018)
Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism
Kaijie Ma et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations
Silvia De Rubeis et al.
MOLECULAR AUTISM (2018)
Variability in Phelan-McDermid syndrome: The impact of the PNPLA3 p.I148M polymorphism
Luigi Boccuto et al.
CLINICAL GENETICS (2018)
Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders
Keerthi Thirtamara Rajamani et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Phelan-McDermid syndrome and cancer predisposition: The value of a karyotype
Kent D. McKelvey et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
C. Vicidomini et al.
MOLECULAR PSYCHIATRY (2017)
Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder
Caroline Richards et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2017)
Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome)
Gillian Reierson et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Clinical Reasoning: A common cause for Phelan-McDermid syndrome and neurofibromatosis type 2 One ring to bind them
Ariel M. Lyons-Warren et al.
NEUROLOGY (2017)
A framework to identify contributing genes in patients with Phelan-McDermid syndrome
Anne-Claude Tabet et al.
NPJ GENOMIC MEDICINE (2017)
Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
Renee J. Zwanenburg et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Neuropsychological phenotype and psychopathology in seven adult patients with Phelan-McDermid syndrome: implications for treatment strategy
J. I. M. Egger et al.
GENES BRAIN AND BEHAVIOR (2016)
Developmental phenotype in Phelan-McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children
Renee J. Zwanenburg et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2016)
Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome
Helene Darville et al.
EBIOMEDICINE (2016)
Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports
Sylvie Serret et al.
BMC PSYCHIATRY (2015)
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment
Hala Harony-Nicolas et al.
JOURNAL OF CHILD NEUROLOGY (2015)
Phelan-McDermid Syndrome and SHANK3: Implications for Treatment
Jesse L. Costales et al.
NEUROTHERAPEUTICS (2015)
Whole Genome Sequencing Reveals a De Novo SHANK3 Mutation in Familial Autism Spectrum Disorder
Sergio I. Nemirovsky et al.
PLOS ONE (2015)
Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome
Vittoria Disciglio et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring
Alexander Kolevzon et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2014)
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Aleksandr Shcheglovitov et al.
NATURE (2013)
Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency
Latha Soorya et al.
MOLECULAR AUTISM (2013)
Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma
B. Zirn et al.
CLINICAL GENETICS (2012)
Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses
Chiara Verpelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)
Sara M. Sarasua et al.
JOURNAL OF MEDICAL GENETICS (2011)
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
K. Phelan et al.
MOLECULAR SYNDROMOLOGY (2011)
Treatment With Valproic Acid Ameliorates ADHD Symptoms in Fragile X Syndrome Boys
Maria Giulia Torrioli et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Julie Gauthier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial
H. Schmidt et al.
JOURNAL OF MEDICAL GENETICS (2009)
Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development
Heather L. Wilson et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood
Anne Philippe et al.
PEDIATRICS (2008)
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Christelle M. Durand et al.
NATURE GENETICS (2007)
Two brothers with 22q13 deletion syndrome and features suggestive of the Clark-Baraitser syndrome
E Tabolacci et al.
CLINICAL DYSMORPHOLOGY (2005)
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms
HL Wilson et al.
JOURNAL OF MEDICAL GENETICS (2003)
Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome
MC Bonaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
